Netherlands· NL-87363af0c49d
Chordyna 2 mg, tabletten
A tizanidine product containing tizanidinehydrochloride, registered in Netherlands by Bausch Health Ireland Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Tizanidine is registered in 14 of 19 countries.
Countries holding a registration under ATC M03BX02 (tizanidine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Tizanidine · ATC M03BX02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tizanidine costs, country by country.
Normalised to the WHO defined daily dose (12 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tizanidine · price per daily dose (12 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.38
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TIZANIDINEHYDROCHLORIDE
- Manufacturer
- Bausch Health Ireland Limited
- Country
- Netherlands (NL)
- ATC code
- M03BX02
- ATC class
- Tizanidine
- Defined daily dose
- 12 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id131476
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
384 interactions on record for tizanidine.
Graded by severity as the source publishes them — 78 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tizanidine · interactions on record
384 records
- 78 severe
- 177 moderate
- 2 minor
- 87 info
Most severe, free to view
- CimetidineA02BA01severe
- FamotidineA02BA03severe
- PapaverineA03AD01severe
- CisaprideA03FA02severe
40 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tizanidine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTIZANDINEDirect_Rx
- United KingdomTizagelan 2mg tabletsG.L. Pharma UK Ltd
- FinlandSirdaludSandoz A/S
- SwitzerlandSirdalud 2 mg, TablettenSandoz Pharmaceuticals AG
- CzechiaSIRDALUDNovartis s.r.o., Praha
- PolandChordynaBausch Health Ireland Ltd.
- NorwaySirdaludNovartis (2)
- IrelandZanaflex 2 mg TabletsIMED Healthcare Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Sirdalud, Sirdalud Mr
- Belgium · Sirdalud
- Bulgaria · Tizanidine Teva, Тизанидин Tева
- Czechia · Sirdalud
- Germany · Sirdalud, Tizanidin Ascend
- Denmark · Sirdalud Retard, Tizanidin Teva
- Estonia · Sirdalud
- Spain · Sirdalud
- Finland · Sirdalud, Sirdalud Retard
- United Kingdom (Northern Ireland) · Tizagelan, Tizanidine
- Greece · Sirdalud
- Croatia · Tizanidin Altamedics
- Hungary · Sirdalud, Sirdalud Mr
- Ireland · Tizanidine Teva
- Italy · Navizan, Sirdalud
- Lithuania · Sirdalud
- Luxembourg · Sirdalud
- Latvia · Sirdalud
- Poland · Chordyna, Sirdalud Mr
- Portugal · Sirdalud, Tizanidina Teva
- Slovenia · Sirdalud
- Slovakia · Sirdalud
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e9ae1acd-0669-468b-abf2-99e5742a3ebd GET /v1/drugs/e9ae1acd-0669-468b-abf2-99e5742a3ebd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h131476_smpc_en.pdf",
"strength": null,
"atc_label": "Tizanidine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131476",
"excipients": [
"LACTOSE 1-WATER",
"MACROGOL 4000",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL, GEPREGELATINEERD",
"SACCHAROSE",
"STEARINEZUUR (E 570)"
],
"substances": [
"TIZANIDINEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131476_piluk.pdf",
"authorised_at": "2026/02/04",
"procedure_number": "NL/H/5844/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "131476",
"additional_monitoring": "N"
}See everything about tizanidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.